Optic Neuritis
Overview
Optic neuritis is an inflammation of the optic nerve that can cause sudden vision loss, eye pain, and color vision changes. It is considered an immune-mediated condition, meaning that the immune system mistakenly targets the optic nerve. While optic neuritis can occur on its own, it is frequently associated with autoimmune diseases such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). In some cases, optic neuritis may be the first symptom of an underlying autoimmune or demyelinating disorder.
Common Symptoms
Sudden vision loss in one eye, pain with eye movement, blurred or dim vision, reduced color perception, flashing lights (photopsia), and a decrease in visual field or peripheral vision.
Coexisting Diseases and Conditions
Optic neuritis is commonly associated with autoimmune and demyelinating diseases such as multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). It may also occur alongside systemic autoimmune diseases like systemic lupus erythematosus (SLE) and sarcoidosis, although less commonly.
Risk Factors and Prevalence
Risk factors for developing optic neuritis include being between the ages of 20 and 40, female sex, genetic predisposition to autoimmune diseases, and having a history of multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), or myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
In rare cases, optic neuritis has been associated with infections such as measles, mumps, rubella, Epstein-Barr virus, and herpes viruses. Older formulations of rabies vaccine, no longer in use, were historically linked to optic neuritis.
Optic neuritis is relatively uncommon but is one of the most frequent early signs of multiple sclerosis. Studies suggest that approximately 15% to 20% of people with MS experience optic neuritis as their first clinical event.
Recent Research
- Optimising the Evaluation of Optic Neuritis YouTube Videos: A Call for Multimedia-Specific Tools and Audience-Oriented Approaches (2025)
- Multi-omics Mendelian Randomization Reveals Immunometabolic Signatures of the Gut Microbiota in Optic Neuritis and the Potential Therapeutic Role of Vitamin B6 (2025)
- Assessment and Outcomes of Pediatric Optic Neuritis in a Tertiary Children’s Hospital in the United Kingdom: A 10-Year Retrospective Review (2025)
- Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment (2023)
- An update on optic neuritis (2023)
- Approach to optic neuritis: An update (2021)
Sources
- Sources
Balcer L. J. (2001). Optic Neuritis. Current treatment options in neurology, 3(4), 389–398. https://doi.org/10.1007/s11940-001-0043-4
Guier CP, Kaur K, Stokkermans TJ. Optic Neuritis. [Updated 2025 Jan 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557853/
16th EUNOS Congress: Rotterdam, The Netherlands, 3–6 June, 2024 Editors’ Introduction. (2024). Neuro-Ophthalmology, 48(sup1), 1–165. https://doi.org/10.1080/01658107.2024.2342769
Bennett J. L. (2019). Optic Neuritis. Continuum (Minneapolis, Minn.), 25(5), 1236–1264. https://doi.org/10.1212/CON.0000000000000768
Toosy, A. T., Mason, D. F., & Miller, D. H. (2014). Optic neuritis. The Lancet. Neurology, 13(1), 83–99. https://doi.org/10.1016/S1474-4422(13)70259-X
Gise, R. A., & Heidary, G. (2020). Update on Pediatric Optic Neuritis. Current neurology and neuroscience reports, 20(3), 4. https://doi.org/10.1007/s11910-020-1024-x
Benard-Seguin, E., & Costello, F. (2023). Optic neuritis: current challenges in diagnosis and management. Current opinion in neurology, 36(1), 10–18. https://doi.org/10.1097/WCO.0000000000001128
Abel, A., McClelland, C., & Lee, M. S. (2019). Critical review: Typical and atypical optic neuritis. Survey of ophthalmology, 64(6), 770–779. https://doi.org/10.1016/j.survophthal.2019.06.001